au.\*:("CHIMENTI, S")
Results 1 to 25 of 69
Selection :
DANNI DA TERAPIA TOPICA CON CORTICOSTEROIDEI = EFFETS NOCIFS DU TRAITEMENT TOPIQUE PAR CORTICOSTEROIDESRIBUFFO A; CARLESIMO O; CHIMENTI S et al.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; NO 4; PP. 241-244; BIBL. 9 REF.Article
SYNOVIAL SARCOMA OF THE FOOTCHIMENTI S; CALVIERI S; RIBUFFO M et al.1982; J. DERMATOL. SURG.; ISSN 0148-0812; USA; DA. 1982; VOL. 8; NO 10; PP. 882-886; BIBL. 25 REF.Article
MALIGNANT MELANOMA OF THE ORAL CAVITYCHIMENTI S; CALVIERI S; RIBUFFO M et al.1981; J. DERMATOL. SURG. ONCOL.; ISSN 0148-0812; USA; DA. 1981; VOL. 7; NO 3; PP. 220-224; BIBL. 11 REF.Article
Isolated B-cell lymphoma of the skin = Lymphome isolé à cellules B de la peauCHIMENTI, S; CALVIERI, S.The Journal of dermatologic surgery and oncology. 1984, Vol 10, Num 4, pp 299-303, issn 0148-0812Article
LA COLLAGENASI BATTERICA NEL TRATTAMENTO DEL CHELOIDE MATURO. PRIMI RISULTATI = LA COLLAGENASE BACTERIENNE DANS LE TRAITEMENT DES CHELOIDES MATURES. PREMIERS RESULTATSIPPOLITO F; FAINA P; CALVIERI S et al.1976; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITAL.; DA. 1976; VOL. 111; NO 5; PP. 317-324; ABS. ANGL.; BIBL. 27 REF.Article
LA COLLAGENASI BATTERICA NEL TRATTAMENTO DEL CHELOIDE MATURO. PRIMI RISULTATI. = LA COLLAGENASE BACTERIENNE DANS LE TRAITEMENT DES CHELOIDES MATURES. PREMIERS RESULTATSIPPOLITO F; FAINA P; CALVIERI S et al.1976; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITAL.; DA. 1976; VOL. 111; NO 5; PP. 317-324; ABS. ANGL.; BIBL. 27 REF.Article
DERMATITE PIGMENTARIA DA AMIODARONE CLORIDRATO = DERMATITE PIGMENTAIRE DUE AU CHLORHYDRATE D'AMIODARONECARLESIMO OA; CALVIERI S; CHIMENTI S et al.1979; G. ITAL. DERMATOL. MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; NO 1-2; PP. 23-29; ABS. ENG; BIBL. 12 REF.Article
Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab SuspensionTALAMONTI, M; TEOLI, M; BOTTI, E et al.Dermatology (Basel). 2011, Vol 222, Num 3, pp 250-255, issn 1018-8665, 6 p.Article
Melanoma-associated markers expression in blood : MUC-18 is associated with advanced stages in melanoma patientsRAPANOTTI, M. C; BIANCHI, L; RICOZZI, I et al.British journal of dermatology (1951). 2009, Vol 160, Num 2, pp 338-344, issn 0007-0963, 7 p.Article
Increased erythropoietin production after myocardial infarction in miceMENGOZZI, M; LATINI, R; SALIO, M et al.Heart (London 1996). 2006, Vol 92, Num 6, pp 838-839, issn 1355-6037, 2 p.Article
Clinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis : results from a phase III international randomized, placebo-controlled trialDUBERTRET, L; STERRY, W; BOS, J. D et al.British journal of dermatology (1951). 2006, Vol 155, Num 1, pp 170-181, issn 0007-0963, 12 p.Article
The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosumHAGMAN, J. H; CARROZZO, A. M; CAMPIONE, E et al.Journal of dermatological treatment. 2001, Vol 12, Num 1, pp 19-22, issn 0954-6634Article
Reduced expression of CDKN2a/p16INK4a in mycosis fungoidesPERIS, K; STANTA, G; FARGNOLI, M. C et al.Archives of dermatological research (Print). 1999, Vol 291, Num 4, pp 207-211, issn 0340-3696Article
Cutaneous epithelioid cell histiocytoma : Immunohistochemical and ultrastructural findings suggesting endothelial originMANENTE, L; SCHMITT, I; MUDA ONETTI, A et al.The American journal of dermatopathology. 1997, Vol 19, Num 5, pp 519-523, issn 0193-1091Conference Paper
The specific effects of 8-methoxypsoralen photoadducts on cell growth : HPLC analysis of monoadduct and crosslink formation in cells exposed to split-dose treatmentSCHMITT, I. M; MAXWELL, V. M; OLACK, G. A et al.Journal of photochemistry and photobiology. B, Biology. 1994, Vol 22, Num 1, pp 17-21, issn 1011-1344Article
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumabTALAMONTI, M; BOTTI, E; GALLUZZO, M et al.British journal of dermatology (1951). 2013, Vol 169, Num 2, pp 458-463, issn 0007-0963, 6 p.Article
The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on InfliximabPAPOUTSAKI, M; TALAMONTI, M; GIUNTA, A et al.Dermatology (Basel). 2010, Vol 221, pp 43-47, issn 1018-8665, 5 p., SUP1Article
Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor BlockersCOSTANZO, A; TALAMONTI, M; BOTTI, E et al.Dermatology (Basel). 2009, Vol 219, Num 1, pp 48-53, issn 1018-8665, 6 p.Article
Interobserver reproducibility of histological features in cutaneous maliqnant melanomaURSO, C; RONGIOLETTI, F; REBORA, A et al.Journal of clinical pathology. 2005, Vol 58, Num 11, pp 1194-1198, issn 0021-9746, 5 p.Article
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of casesBIANCHI, L; ORLANDI, A; CAMPIONE, E et al.British journal of dermatology (1951). 2004, Vol 151, Num 1, pp 148-156, issn 0007-0963, 9 p.Article
Treatment of vitiligo with the 308 nm excimer laserESPOSITO, M; SODA, R; COSTANZO, A et al.Clinical and experimental dermatology (Print). 2004, Vol 29, Num 2, pp 133-137, issn 0307-6938, 5 p.Article
CDKN2a/p16INKa mutations and lack of p19ARF involvement in familial melanoma kindredsFARGNOLI, M. C; CHIMENTI, S; KELLER, G et al.Journal of investigative dermatology. 1998, Vol 111, Num 6, pp 1202-1206, issn 0022-202XArticle
Analysis of microsatellite instability and loss of heterozygosity in keratoacanthomaPERIS, K; MAGRINI, F; KELLER, G et al.Archives of dermatological research (Print). 1997, Vol 289, Num 4, pp 185-188, issn 0340-3696Article
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinomaCHIMENTI, S; PERIS, K; DI CRISTOFARO, S et al.Dermatology (Basel). 1995, Vol 190, Num 3, pp 214-217, issn 1018-8665Conference Paper
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE studyTHACI, D; ORTONNE, J.-P; UNNEBRINK, K et al.British journal of dermatology (1951). 2010, Vol 163, Num 2, pp 402-411, issn 0007-0963, 10 p.Article
